Global Psychedelic Drugs Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Published Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 295
  • No of Figures: 85

Global Psychedelic Drugs Market, By Source (Synthetic & Natural), Type (Empathogens, Dissociatives & Others), Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin & Others), Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder & Others), Route of Administration (Oral, Inhalation & Injectable), End User (Hospitals, Specialty Clinics, Homecare & Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy & Online Pharmacy), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Poland, Switzerland, Netherlands, Hungary, Austria, Norway, Ireland, Belgium, Lithuania, Rest of Europe, India, Australia, South Korea, Singapore, Malaysia, Saudi Arabia, Israel, Egypt, U.A.E, South Africa, Rest of Middle East and Africa, Brazil, Argentina & Rest of South America) - Market Trends and Forecast to 2029.

Psychedelic Drugs Market

Global Market Analysis and Insights : Global Psychedelic Drugs Market

Global psychedelic drugs market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 13.3% in the forecast period of 2022 to 2029 and is expected to reach USD 8,020.01 million by 2029 from USD 2,992.51 million in 2021. Rising prevalence of mental depression and anxiety and availability of off label drugs are the major drivers which propelled the demand of the market in the forecast period.

Psychedelic drugs involve various types of chemical substances including LSD and chemical extracted from plants. Psychedelic drugs have the ability to change or enhance the sensory perceptions, thought processes, energy levels and have also been reported to facilitate spiritual experiences. Psychedelic drugs can be categorized into empathogens and dissociative drugs (such as PCP) and serotonergic (classic hallucinogens) such as LSD. Both the types of psychedelic drugs can cause hallucinations and feeling of sensation, moreover, dissociative drugs can make a person to fell out of control from their body or environment and makes them feel disconnected. Based on the source, psychedelic drugs have been categorized under natural and synthetic types. These drugs have wide applications in the treatment of major depressive disorder, post-traumatic stress disorder, panic disorder, treatment-resistant depression and opiate addiction among others. Psychedelic drugs are also known by several other names such as LSD (lysergic acid derivative) which are also known as blotter, dots, sugar, acid, trips and window pane, ketamine are also known as vitamin K, bump, green, K/special K, purple and super acid, PCP are also known as angel/angel dust, boat/love boat, peace, killer weed, super grass and ozone.

The increasing prevalence of depression and mental disorders worldwide as the psychedelic drugs have repetitively proven for its high rates of effectiveness is expected to act as driver for the growth of the market. The high cost of treatment is expected to act as challenge for the growth of the market. Further, rising awareness towards mental health by various non-profit, non-governments, government, national, international organizations is expected to act as opportunity for the growth of the market. However, the side effects associated may expected to challenge the market growth.

The Global psychedelic drugs report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Psychedelic Drugs Market

Global Psychedelic Drugs Market Scope and Market Size

Global psychedelic drugs market is segmented into seven notable segments which are by source, type, drugs, application, route of administration, end user & distribution channel.

  • On the basis of source, the global psychedelic drugs market is segmented into synthetic and natural. In 2022, the synthetic segment is expected to dominate the global psychedelic drugs market as most of the products are made from chemicals that are man-made with very few products (such as psilocybin) made from natural ingredients.
  • On the basis of type, the global psychedelic drugs market is segmented into empathogens, dissociatives, and others. In 2022, the empathogens segment is expected to dominate the global psychedelic drugs market as it produce experiences of emotional communion, oneness, relatedness and used for treatment of cataplexy, narcolepsy and related disorders.
  • On the basis of drugs, the global psychedelic drugs market is segmented into gamma-hydroxybutyric acid, ketamine, psilocybin and others. In 2022, the gamma-hydroxybutyric acid segment is expected to dominate the global psychedelic drugs market as xyrem whose active ingredient is gamma-hydroxybutyric acid, from Jazz Pharmaceutical is one of the oldest available psychedelic drugs available in the market holding a major share and belongs to the drug class.
  • On the basis of application, the global psychedelic drugs market is segmented into narcolepsy, treatment resistant depression major depressive disorder, opiate addiction, post-traumatic stress disorder and others. In 2022, the narcolepsy segment is expected to dominate the global psychedelic drugs market as large number of population suffers from narcolepsy.
  • On the basis of route of administration, the global psychedelic drugs market is segmented into oral, inhalation and injectable. In 2022, the oral segment is expected to dominate the global psychedelic drugs market as it is preferred over the various other administration routes of drug delivery. It offers several advantages including safety, easier patient compliance and pain/inconvenience avoidance.
  • On the basis of end user, the global psychedelic drugs market is segmented into hospitals, specialty clinics, homecare and others. In 2022, the hospitals segment is expected to dominate the global psychedelic drugs market due to the high patient load and most of the drugs are given under doctor’s supervision. Due to this reason, hospitals segment dominates the psychedelic drugs market.
  • On the basis of distribution channel, the global psychedelic drugs market is segmented into hospitals pharmacy, retail pharmacy and online pharmacy. In 2022, the hospitals pharmacy segment is expected to dominate the global psychedelic drugs market as it holds the largest market share as more number of patients are treated in hospitals and the demand for medicines in hospital pharmacy increases.

Psychedelic Drugs Market

Global Psychedelic Drugs Market Country Level Analysis

Global psychedelic drugs market is analysed and market size information is provided on basis of seven notable segments which are by source, type, drugs, application, route of administration, end user & distribution channel.

Countries included in global psychedelic drugs market are U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Poland, Switzerland, Netherlands, Hungary, Austria, Norway, Ireland, Belgium, Lithuania, Rest of Europe, India, Australia, South Korea, Singapore, Malaysia, Saudi Arabia, Israel, Egypt, U.A.E, South Africa, Rest of Middle East and Africa, Brazil, Argentina & Rest of South America.

North America is expected to grow with the fastest CAGR in the forecasted periods due to the advancements in healthcare sector, rising R&D, and increasing awareness among people. Europe is expected to grow due to increasing prevalence of mental disorders and effectiveness of psychedelic to treat such disorders. Asia-Pacific is expected to grow due to the growing acceptance of psychedelic to treat depression.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Strategic Initiatives by Market Players Is Creating New Opportunities in the Global Psychedelic Drugs Market

Global psychedelic drugs market also provides you with detailed market analysis for every country growth in psychedelic drugs, impact of advancement in global psychedelic drugs and changes in regulatory scenarios with their support for the global psychedelic drugs market. The data is available for historic period 2011 to 2020.

Competitive Landscape and Global Psychedelic Drugs Market Share Analysis

Global psychedelic drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to global psychedelic drugs market.

The major companies providing psychedelic drugs are Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson Services, Inc.), Hikma Pharmaceuticals PLC, COMPASS, Verrian, Pfizer Inc., F. Hoffmann-La Roche Ltd, Jazz Pharmaceuticals, Inc., PharmaTher Inc., Avadel, Celon Pharma S.A., NeuroRx, Inc., usonainstitute.org, Mind Medicine, Inc., Cybin Corp., EmpathBio, GABA Therapeutics, Inc., DemeRx among others.

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the Global psychedelic drugs market.

For instance,

  • In August 2020, Janssen Pharmaceuticals, Inc. received approval for its Spravato nasal spray for treatment of suicidal people. As per the data published, approximately 11% to 12% of Americans suffers from major depressive disorder that led them to commit suicide. Hence, this approval provided these patients with a remarkable therapy and allowed company to generate more revenue.
  • In January 2020, Jazz Pharmaceuticals, Inc. received marketing authorization for Sunosi (solriamfetol) from European Commission. As per the approval, the company can market the product for treatment of narcolepsy or obstructive sleep apnoea, moreover it is effective in treatment of excessive daytime sleepiness. This approval paved the way for the company to penetrate its root in large European market.

Customization Available: Global Psychedelic Drugs Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 GLOBAL PSYCHEDELIC DRUGS MARKET, PIPELINE ANALYSIS

TABLE 2 PSYCHEDELICS RESEARCH, IN EUROPE

TABLE 3 MENTAL ILLNESS IN THE U.S. ADULTS, IN 2020

TABLE 4 MENTAL DISORDERS, IN THE U.S. ADULTS, IN 2020

TABLE 5 MENTAL DISORDERS CAUSED BY USAGE OF SUBSTANCE DISORDERS, IN WORLD, IN 2017

TABLE 6 DRUG DEVELOPMENT PATHWAY FOR FDA APPROVAL OF NEW MEDICATIONS

TABLE 7 THE 1971 UN CONVENTION ON PSYCHOTROPIC SUBSTANCES

TABLE 8 COST OF PSYCHEDELIC DRUGS

TABLE 9 TOTAL COSTS (DIRECT AND INDIRECT) OF MENTAL HEALTH PROBLEMS IN EU COUNTRIES, IN MILLION AND AS A SHARE OF GDP, IN 2015

TABLE 10 PSYCHEDELIC DRUGS R&D ACTIVITIES

TABLE 11 GLOBAL PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 12 GLOBAL EMPATHOGENS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 13 GLOBAL DISSOCIATIVES IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 GLOBAL OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 15 GLOBAL PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 16 GLOBAL SYNTHETIC IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 GLOBAL NATURAL IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 GLOBAL PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 19 GLOBAL GAMMA-HYDROXYBUTYRIC ACID IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 GLOBAL KETAMINE IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 GLOBAL PSILOCYBIN IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 GLOBAL OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 23 GLOBAL PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 24 GLOBAL NARCOLEPSY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 GLOBAL TREATMENT RESISTANT DEPRESSION IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 26 GLOBAL MAJOR DEPRESSIVE DISORDER IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 GLOBAL OPIATE ADDICTION IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 28 GLOBAL POST-TRAUMATIC STRESS DISORDER IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 GLOBAL OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 GLOBAL PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 31 GLOBAL ORAL IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 32 GLOBAL INHALATION IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 GLOBAL INJECTABLE IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 34 GLOBAL PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 35 GLOBAL HOSPITALS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 GLOBAL SPECIALTY CLINICS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 GLOBAL HOMECARE IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 38 GLOBAL OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 39 GLOBAL PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 40 GLOBAL HOSPITALS PHARMACY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 GLOBAL RETAIL PHARMACY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 42 GLOBAL ONLINE PHARMACY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 43 GLOBAL PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 44 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 45 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 46 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 47 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 48 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 49 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 50 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 51 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 52 U.S. PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 53 U.S. PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 54 U.S. PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 55 U.S. PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 56 U.S. PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 57 U.S. PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 58 U.S. PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 59 CANADA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 60 CANADA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 61 CANADA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 62 CANADA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 63 CANADA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 64 CANADA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 65 CANADA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 66 MEXICO PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 67 MEXICO PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 68 MEXICO PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 69 MEXICO PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 70 MEXICO PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 71 MEXICO PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 72 MEXICO PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 73 EUROPE PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 74 EUROPE PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 75 EUROPE PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 76 EUROPE PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 77 EUROPE PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 78 EUROPE PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 79 EUROPE PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 80 EUROPE PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 81 GERMANY PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 82 GERMANY PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 83 GERMANY PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 84 GERMANY PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 85 GERMANY PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 86 GERMANY PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 87 GERMANY PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 88 U.K. PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 89 U.K. PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 90 U.K. PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 91 U.K. PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 92 U.K. PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 93 U.K. PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 94 U.K. PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 95 FRANCE PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 96 FRANCE PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 97 FRANCE PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 98 FRANCE PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 99 FRANCE PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 100 FRANCE PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 101 FRANCE PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 102 ITALY PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 103 ITALY PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 104 ITALY PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 105 ITALY PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 106 ITALY PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 107 ITALY PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 108 ITALY PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 109 SPAIN PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 110 SPAIN PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 111 SPAIN PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 112 SPAIN PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 113 SPAIN PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 114 SPAIN PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 115 SPAIN PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 116 RUSSIA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 117 RUSSIA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 118 RUSSIA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 119 RUSSIA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 120 RUSSIA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 121 RUSSIA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 122 RUSSIA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 123 POLAND PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 124 POLAND PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 125 POLAND PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 126 POLAND PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 127 POLAND PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 128 POLAND PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 129 POLAND PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 130 SWITZERLAND PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 131 SWITZERLAND PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 132 SWITZERLAND PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 133 SWITZERLAND PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 134 SWITZERLAND PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 135 SWITZERLAND PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 136 SWITZERLAND PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 137 NETHERLANDS PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 138 NETHERLANDS PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 139 NETHERLANDS PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 140 NETHERLANDS PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 141 NETHERLANDS PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 142 NETHERLANDS PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 143 NETHERLANDS PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 144 HUNGARY PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 145 HUNGARY PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 146 HUNGARY PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 147 HUNGARY PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 148 HUNGARY PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 149 HUNGARY PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 150 HUNGARY PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 151 AUSTRIA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 152 AUSTRIA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 153 AUSTRIA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 154 AUSTRIA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 155 AUSTRIA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 156 AUSTRIA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 157 AUSTRIA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 158 NORWAY PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 159 NORWAY PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 160 NORWAY PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 161 NORWAY PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 162 NORWAY PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 163 NORWAY PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 164 NORWAY PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 165 IRELAND PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 166 IRELAND PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 167 IRELAND PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 168 IRELAND PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 169 IRELAND PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 170 IRELAND PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 171 IRELAND PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 172 BELGIUM PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 173 BELGIUM PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 174 BELGIUM PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 175 BELGIUM PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 176 BELGIUM PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 177 BELGIUM PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 178 BELGIUM PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 179 LITHUANIA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 180 LITHUANIA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 181 LITHUANIA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 182 LITHUANIA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 183 LITHUANIA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 184 LITHUANIA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 185 LITHUANIA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 186 REST OF EUROPE PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 187 ASIA-PACIFIC PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 188 ASIA-PACIFIC PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 189 ASIA-PACIFIC PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 190 ASIA-PACIFIC PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 191 ASIA-PACIFIC PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 192 ASIA-PACIFIC PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 193 ASIA-PACIFIC PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 194 ASIA-PACIFIC PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 195 INDIA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 196 INDIA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 197 INDIA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 198 INDIA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 199 INDIA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 200 INDIA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 201 INDIA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 202 AUSTRALIA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 203 AUSTRALIA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 204 AUSTRALIA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 205 AUSTRALIA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 206 AUSTRALIA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 207 AUSTRALIA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 208 AUSTRALIA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 209 SOUTH KOREA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 210 SOUTH KOREA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 211 SOUTH KOREA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 212 SOUTH KOREA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 213 SOUTH KOREA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 214 SOUTH KOREA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 215 SOUTH KOREA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 216 SINGAPORE PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 217 SINGAPORE PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 218 SINGAPORE PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 219 SINGAPORE PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 220 SINGAPORE PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 221 SINGAPORE PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 222 SINGAPORE PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 223 MALAYSIA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 224 MALAYSIA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 225 MALAYSIA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 226 MALAYSIA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 227 MALAYSIA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 228 MALAYSIA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 229 MALAYSIA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 230 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 231 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 232 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 233 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 234 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 235 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 236 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 237 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 238 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 239 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 240 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 241 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 242 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 243 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 244 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 245 ISRAEL PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 246 ISRAEL PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 247 ISRAEL PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 248 ISRAEL PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 249 ISRAEL PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 250 ISRAEL PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 251 ISRAEL PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 252 EGYPT PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 253 EGYPT PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 254 EGYPT PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 255 EGYPT PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 256 EGYPT PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 257 EGYPT PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 258 EGYPT PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 259 U.A.E PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 260 U.A.E PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 261 U.A.E PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 262 U.A.E PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 263 U.A.E PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 264 U.A.E PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 265 U.A.E PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 266 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 267 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 268 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 269 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 270 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 271 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 272 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 273 SOUTH AMERICA PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 274 SOUTH AMERICA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 275 SOUTH AMERICA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 276 SOUTH AMERICA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 277 SOUTH AMERICA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 278 SOUTH AMERICA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 279 SOUTH AMERICA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 280 SOUTH AMERICA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 281 BRAZIL PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 282 BRAZIL PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 283 BRAZIL PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 284 BRAZIL PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 285 BRAZIL PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 286 BRAZIL PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 287 BRAZIL PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 288 ARGENTINA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 289 ARGENTINA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 290 ARGENTINA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 291 ARGENTINA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 292 ARGENTINA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 293 ARGENTINA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 294 ARGENTINA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 295 REST OF SOUTH AMERICA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The Psychedelic Drugs Market is growing with a CAGR of 13.3% in the forecast period of 2021 to 2028
The Application Segment Psychedelic Drugs Market are Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder, Others
The major companies providing psychedelic drugs are Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson Services, Inc.), Hikma Pharmaceuticals PLC, COMPASS, Verrian, Pfizer Inc., F. Hoffmann-La Roche Ltd, Jazz Pharmaceuticals, Inc., PharmaTher Inc., Avadel, Celon Pharma S.A., NeuroRx, Inc., usonainstitute.org among other domestic players.
Psychedelic Market is expected to reach USD 7,567.52 million by 2028